Calistoga Pharmaceuticals' Acquisition

Calistoga Pharmaceuticals was acquired by Gilead Sciences on February 07, 2011.

Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseas…

Articles about Calistoga Pharmaceuticals' Acquisition: